 - WOCBP receiving nivolumab will be instructed to adhere to contraception for a period of 31 weeks after the last dose of investigational product; these durations have been calculated using the upper limit of the half-life for nivolumab 25 days and are based on the protocol requirement that WOCBP use contraception for 5 half-lives plus 30 days 